Report Summarizes Breast Cancer Study Findings from Tisch Cancer Institute [Abstract PO1-01-06: Patterns in use and tolerance of adjuvant neratinib in patients with hormone receptor (HR)-positive, HER2-positive early-stage breast cancer]

Media coverage

• Title	Report Summarizes Breast Cancer Study Findings from Tisch Cancer Institute [Abstract PO1-01-06: Patterns in use and tolerance of adjuvant neratinib in patients with hormone receptor (HR)-positive, HER2-positive early-stage breast cancer]
  Media name/outlet	NewsRx Women's Health Daily
  Country/Territory	United States
  Date	20/05/24
  Persons	Amy Tiersten